Martin Turner

Martin Turner
Martin Turner
Martin Turner
Head of Programme and Associate Director
Martin Turner

Research Summary

The molecular processes which control the development and function of lymphocytes have been extensively studied from the perspective of cell surface receptors and their associated intracellular signalling.

Also, many transcription factors which repress or promote the production of mRNA have been identified as being essential for lymphocyte development and activation.  These studies have revealed that genes, molecules and pathways that are used early in the development of lymphocytes are re-used in fully mature cells as part of the response to infection.

We are developing tools for measuring gene expression in rare cell populations.  We also use genome wide approaches to study RNA turnover and translation and to identify the targets of RNA binding proteins.

We aim to characterise fundamental mechanisms controlling lymphocyte development and function throughout the life-course.  These include understanding the roles of RNA binding proteins in lymphocyte development and activation. 

In the future explaining how these are integrated with signal transduction pathways, microRNA and transcription factor networks will be an important step towards a systems level understanding of immunity.

Current Work

Multiomics analysis couples mRNA turnover and translational control of glutamine metabolism to the differentiation of the activated CD4+ T cell

Open Access symbol

Matheson LS, Petkau G, Sáenz-Narciso B, D'Angeli V, McHugh J, Newman R, Munford H, West J, Chakraborty K, Roberts J, Łukasiak S, Díaz-Muñoz MD, Bell SE, Dimeloe S, Turner M
Scientific Reports, 2022
PMID: 36385275


A functional screen of RNA binding proteins identifies genes that promote or limit the accumulation of CD138+ plasma cells

Open Access symbol

Turner DJ, Saveliev A, Salerno F, Matheson LS, Screen M, Lawson H, Wotherspoon D, Kranc KR, Turner M
ELIFE, 2022
PMID: 35451955


The timing of differentiation and potency of CD8 effector function is set by RNA binding proteins.

Open Access symbol

Petkau G, Mitchell TJ, Chakraborty K, Bell SE, D'Angeli V, Matheson L, Turner DJ, Saveliev A, Gizlenci O, Salerno F, Katsikis PD, Turner M
Nature Communications, 2022
PMID: 35477960


Efficient homing of antibody-secreting cells to the bone marrow requires RNA-binding protein ZFP36L1

Open Access symbol

Saveliev A, Bell SE, Turner M
The Journal of experimental medicine, 2021
PMID: 33306108


RNA-binding proteins control gene expression and cell fate in the immune system

Turner M, Díaz-Muñoz MD
Nature Immunology, 2018
PMID: 29348497



Zfp36l1 establishes the high affinity CD8 T cell response by directly linking TCR affinity to cytokine sensing

Georg Petkau, Twm J. Mitchell, Marian Jones Evans, Louise Matheson, Fiamma Salerno, Martin Turner


An integrated proteome and transcriptome of B cell maturation defines poised activation states of transitional and mature B cells

Fiamma Salerno, Andrew J. M. Howden, Louise S. Matheson, Özge Gizlenci, Michael Screen, Holger Lingel, Monika C. Brunner-Weinzierl, Martin Turner


Zfp36l1 and Zfp36l2 balances proliferation and differentiation in the developing retina

Fuguo Wu, Tadeusz Kaczynski, Louise S. Matheson, Tao Liu, Jie Wang, Martin Turner, Xiuqian Mu

Group Members

Martin Turner

Head of Programme and Associate Director

Sarah Bell

Senior Research Associate

Ozge Gizlenci

Postdoc Research Scientist

Tahmid Hussain

PhD Student

Marian Jones Evans

PhD Student

Twm Mitchell

Postdoc Research Scientist

Georg Petkau

Postdoc Research Scientist

Francesca Rossi

Marie Curie Fellow

Beatriz Saenz

Postdoc Research Scientist

Fiamma Salerno

Visiting Scientist

Alexander Saveliev

Postdoc Research Scientist

Michael Screen

Postdoc Research Scientist